Royal jelly is the well-known queen-maker for the honey bee Apis mellifera, and has documented crossspecies effects on longevity, fertility, and regeneration in mammals. Given larger body size and shorter developmental times in honey bee queens despite genetic similarity to workers, we reasoned that royal jelly may impact stem cell function. Here we show, for the first time, stemness maintenance activities in mouse embryonic stem cells and enhanced wound healing in dorsal mouse wounds.
METHODS: J1 mESCs were grown in medium containing KnockOut D-MEM and 1,000U/ml mouse LIF. For 2i conditions, mESCs were cultured in serum-free 2i media containing 1,000U/ml mouse LIF, 1uM PD0325901, and 3uM CHIR99021. To assess teratoma formation capacity, -LIF+Royal Jelly mESCs were injected subcutaneously into flanks of 8-week-old SCID/Beige mice. RNA-seq libraries were generated and deep sequencing was performed. Royal jelly mass spectrometry was performed, and data-dependent collision induced fragmentation was evaluated on the top 10 most intense +2 and +3 ions. Individual royal jelly components were also injected into full-thickness dorsal wounds in mice and wound healing rates were determined. RESULTS: mESCs readily differentiated upon LIF withdrawal, however addition of royal jelly, in the absence of LIF, resulted in formation of undifferentiated colonies and upregulation of pluripotent genes. Royal jelly maintained a high pStat3 state, suggesting activation of a Stat3-driven LIF-independent pathway for mESC self-renewal. mESCs grown in -LIF+Royal Jelly were also capable of teratoma formation in mice. RNA-seq analysis revealed 1445 upregulated and 1885 downregulated genes in response to royal jelly. GO term analysis revealed enrichment of genes involved with proliferation and stemness among upregulated gene sets. Furthermore, GO term analysis of 'royal jellyresponsive' genes demonstrated enrichment for metabolic and biosynthetic processes, similar to ground state conditions. To obtain an unbiased view of royal jelly and what components may be responsible for its stemness effects, we performed liquid chromatography-mass spectrometry. Six of 10 predominant proteins belonged to a highly homologous group known as major royal jelly proteins, one of which was capable of maintaining mESCs in a pluripotent ground state and enhancing wound healing in mice.
CONCLUSION:
Royal jelly can functionally replace LIF and maintain self-renewal and pluripotency in mESCs, effecting a phenotype similar to ground state pluripotent stem cells. Our findings indicate that royal jelly can regulate the dynamic state of stem cells in non-insect species, uncovering an important heretofore unappreciated innate program for stem cell self-renewal with broad implications in understanding the molecular regulation of stem cell fate and wound healing. 
METHODS:
This study represents scheduling data gathered from a single institution's OR scheduling times. "First starts" are defined as surgeries scheduled as the first case in a particular operating room. Surgeon "call in" is the surgeon notifying the OR staff he or she is in the building. Data gathered represents 238 scheduled first starts over 1 year. Included were all surgical specialties with first start times. Delays in "first start" cases were attributed to one of the following: "2nd Room" (start time intentionally staggered to allow for two simultaneous cases with first start times) "Anesthesia related" (such as nerve blocks causing delay, or delay in anesthesia pre-operative evaluation), "Patient Modifiable Delay" (such as patient not having ride, not going to pre-op clinic as previously instructed, or patient arriving late), "Patient Non-modifiable Delay" (patient acutely ill on day of surgery), "Surgeon Modifiable Delay" (surgeon not calling in, surgeon late for arrival, office mis-scheduling, or industry rep late with necessary equipment), "Surgeon Non-modifiable Delay (one surgeon helping another due to acutely decompensated patient), or "unknown" (no reason listed for delay). Once data was gathered, a statistical analysis was performed.
RESULTS:
The surgeon "calling in" was weakly associated with on-time starts (r=0.18). The surgeon "calling in" did not relate to all-cause delays (r=-0.04). Moreover, the greatest delays were caused by Patient Modifiable Factors
